Sana Biotechnology Balance Sheet
NASDAQ: SANAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Sana Biotechnology financial position
At the end of fiscal 2025, Sana Biotechnology reported total assets of $416.9 million, down 16.8% from a year earlier against total liabilities of $256.0 million. Shareholders' equity stood at $160.9 million, or 38.6% of assets. The company held $71.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 1.89, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Sana Biotechnology balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 71.87M | 127.57M | 133.52M | 176.76M | 253.03M | 124.81M | 81.81M |
| Short-Term Investments | 66.51M | 24.93M | 71.68M | 247.20M | 297.97M | 253.46M | — |
| Total Current Assets | 148.68M | 160.81M | 213.51M | 444.44M | 558.10M | 384.47M | — |
| Property, Plant & Equipment | 26.91M | 77.31M | 70.69M | 66.92M | 65.46M | 46.77M | — |
| Goodwill | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | — |
| Intangible Assets | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | — |
| Long-Term Investments | — | — | — | 10.05M | 195.88M | 33.73M | — |
| Total Assets | 416.89M | 501.02M | 565.30M | 822.72M | 1.13B | 730.30M | — |
| Accounts Payable | 1.67M | 5.21M | 4.11M | 2.86M | 2.22M | 2.25M | — |
| Total Current Liabilities | 78.73M | 45.43M | 64.49M | 111.50M | 99.23M | 31.45M | — |
| Total Liabilities | 256.01M | 250.52M | 277.79M | 323.40M | 400.90M | 298.58M | — |
| Shareholders' Equity | 160.88M | 250.50M | 287.51M | 499.31M | 728.50M | -421.18M | -142.54M |
| Retained Earnings | -1.85B | -1.60B | -1.34B | -1.05B | -785.36M | -429.43M | — |
| Net Cash (Debt) | 138.38M | 152.50M | 205.19M | 423.96M | 551.00M | 378.26M | 81.81M |
| Shares Outstanding | 266.73M | 223.92M | 197.86M | 191.02M | 184.93M | 16.17M | — |
This table shows 7 annual periods of Sana Biotechnology's balance sheet, from FY 2025 back to FY 2019, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow SANA's reporting calendar. What is a balance sheet?